Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe In Situ Hybridization Market, by Technology
1.4.2 Europe In Situ Hybridization Market, by End Use
1.4.3 Europe In Situ Hybridization Market, by Application
1.4.4 Europe In Situ Hybridization Market, by Product
1.4.5 Europe In Situ Hybridization Market, by Probe
1.4.6 Europe In Situ Hybridization Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe In Situ Hybridization Market by Technology
3.1 Europe Fluorescent In Situ Hybridization (FISH) Market by Country
3.2 Europe Chromogenic In Situ Hybridization (CISH) Market by Country
Chapter 4. Europe In Situ Hybridization Market by End-use
4.1 Europe Research & Diagnostic Laboratories Market by Country
4.2 Europe Academic Institutes Market by Country
4.3 Europe CROs Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe In Situ Hybridization Market by Application
5.1 Europe Cancer Market by Country
5.2 Europe Cytogenetics Market by Country
5.3 Europe Developmental Biology Market by Country
5.4 Europe Infectious Diseases Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe In Situ Hybridization Market by Product
6.1 Europe Instruments Market by Country
6.2 Europe Kits & Probes Market by Country
6.3 Europe Software Market by Country
6.4 Europe Services Market by Country
Chapter 7. Europe In Situ Hybridization Market by Probe
7.1 Europe DNA Market by Country
7.2 Europe RNA Market by Country
Chapter 8. Europe In Situ Hybridization Market by Country
8.1 Germany In Situ Hybridization Market
8.1.1 Germany In Situ Hybridization Market by Technology
8.1.2 Germany In Situ Hybridization Market by End-use
8.1.3 Germany In Situ Hybridization Market by Application
8.1.4 Germany In Situ Hybridization Market by Product
8.1.5 Germany In Situ Hybridization Market by Probe
8.2 UK In Situ Hybridization Market
8.2.1 UK In Situ Hybridization Market by Technology
8.2.2 UK In Situ Hybridization Market by End-use
8.2.3 UK In Situ Hybridization Market by Application
8.2.4 UK In Situ Hybridization Market by Product
8.2.5 UK In Situ Hybridization Market by Probe
8.3 France In Situ Hybridization Market
8.3.1 France In Situ Hybridization Market by Technology
8.3.2 France In Situ Hybridization Market by End-use
8.3.3 France In Situ Hybridization Market by Application
8.3.4 France In Situ Hybridization Market by Product
8.3.5 France In Situ Hybridization Market by Probe
8.4 Russia In Situ Hybridization Market
8.4.1 Russia In Situ Hybridization Market by Technology
8.4.2 Russia In Situ Hybridization Market by End-use
8.4.3 Russia In Situ Hybridization Market by Application
8.4.4 Russia In Situ Hybridization Market by Product
8.4.5 Russia In Situ Hybridization Market by Probe
8.5 Spain In Situ Hybridization Market
8.5.1 Spain In Situ Hybridization Market by Technology
8.5.2 Spain In Situ Hybridization Market by End-use
8.5.3 Spain In Situ Hybridization Market by Application
8.5.4 Spain In Situ Hybridization Market by Product
8.5.5 Spain In Situ Hybridization Market by Probe
8.6 Italy In Situ Hybridization Market
8.6.1 Italy In Situ Hybridization Market by Technology
8.6.2 Italy In Situ Hybridization Market by End-use
8.6.3 Italy In Situ Hybridization Market by Application
8.6.4 Italy In Situ Hybridization Market by Product
8.6.5 Italy In Situ Hybridization Market by Probe
8.7 Rest of Europe In Situ Hybridization Market
8.7.1 Rest of Europe In Situ Hybridization Market by Technology
8.7.2 Rest of Europe In Situ Hybridization Market by End-use
8.7.3 Rest of Europe In Situ Hybridization Market by Application
8.7.4 Rest of Europe In Situ Hybridization Market by Product
8.7.5 Rest of Europe In Situ Hybridization Market by Probe
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 PerkinElmer, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Agilent Technologies, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Merck Group
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.7 Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Danaher Corporation (Leica Biosystems)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.9 F. Hoffmann-La Roche Ltd.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.10. Neogenomics, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Research & Development Expenses
Unique Offerings 